OLANDER CLINICAL CONSULTING K/S: Financial statements 2017
CVR: 35860177
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,323,163 and a net result of DKK 1,296,700 compared with DKK 1,455,934 the year before. That is a decrease of 10.9% compared with the year before. Equity in the 2017 report amounted to DKK 517,621. The solvency ratio was 88.2%.
- Gross Profit
- DKK 1,323,163
- Profit/Loss
- DKK 1,296,700
- Equity
- DKK 517,621
- Total Assets
- DKK 586,568
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.3M | 1.3M | 518K | - |
| 2016 | - | 1.5M | 1.5M | 699K | - |
| 2015 | - | 817K | 790K | 683K | 1 |
Official annual report
Keep an eye on OLANDER CLINICAL CONSULTING K/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
OLANDER CLINICAL CONSULTING K/S has published its annual report for 2016. Gross profit came to DKK 1,485,647, and the net result was DKK 1,455,934.
About OLANDER CLINICAL CONSULTING K/S
OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity in the 2025 report amounted to DKK 303,261.
